Prescribing medication in consideration of shared decision making and aspects of drug therapy

Not Applicable

• Conditions: E00-E90; Endocrine, nutritional and metabolic diseases

• Registration Number: DRKS00008789
• Lead Sponsor: Institut für Pharmakologie der Universität zu Köln

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-10-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

consent to participating in the study; subject of consultation is either prescription of new medication or adjustment of preexisting pharmaco-therapy; Patients suffer from lipometabolic disorder and / or diabetes mellitus; minimum age 18 years; duration of therapy will be several weeks at least

Exclusion Criteria

limitation of linguistic, physical or cognitive functioning that could possibly preclude appropriate informing about the study or affect the prescribed medication therapy negatively; Patient initially refuses new prescription or adjustment of preexisting medication; new prescription or adjustment of preexisting medication are not subject of the actual conversation between patient and physician;
the reason for the consultation is a therapy of an acute condition that will last less than two weeks

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
the guide's feasibility: is the guide feasible for clinical practice? Physicians will be surveyed by questionnaire after using the guide.

Secondary Outcome Measures

Name	Time	Method
satisfaction (physicians): questionnaire before and after using the guide, Satisfaction (patients): questionnaires (SIMS-D, KPF-A) applied to interventional and control-patients